{"name":"Centre for the AIDS Programme of Research in South Africa","slug":"centre-for-the-aids-programme-of-research-in-south-africa","ticker":"","exchange":"","domain":"","description":"CAPRISA is the name of an AIDS research center based in Durban, South Africa.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Tenofovir, lamivudine and efavirenz","genericName":"Tenofovir, lamivudine and efavirenz","slug":"tenofovir-lamivudine-and-efavirenz","indication":"HIV-1 infection in treatment-naïve and treatment-experienced patients","status":"marketed"}]}],"pipeline":[{"name":"Tenofovir, lamivudine and efavirenz","genericName":"Tenofovir, lamivudine and efavirenz","slug":"tenofovir-lamivudine-and-efavirenz","phase":"marketed","mechanism":"This fixed-dose combination of three antiretroviral drugs inhibits HIV reverse transcriptase and integrase to suppress viral replication.","indications":["HIV-1 infection in treatment-naïve and treatment-experienced patients","Reduction of mother-to-child transmission of HIV-1"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPY004dlozTGZVaEgzV1FDbGFmekFfMWRKNGVEa2tSTF9NTGpUeThEQWlVQ1VWQzFuUkVWc05nalRJblhUUUM4Nk4zcGRHenh4ODYwYTZiWXdxZDZWNXl5VkNXRzdhWGI0LXhSN3hXYUR2bC1TTXZ3Z0RKQ3Q3Y0M4a3hoR2VoZVQ1WElJbGU4M0R5LTViU25FRExVNDhjaDlrUkFBR3F6UGpfUQ?oc=5","date":"2025-10-27","type":"pipeline","source":"spotlightnsp.co.za","summary":"ARVs without a script: What next after major court ruling? - spotlightnsp.co.za","headline":"ARVs without a script: What next after major court ruling?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9wMzJhQTQtSEpXdl9pMk5DSzNrQ0dXY0RHcnd2V2lLd18zRzVNQm4wWGlvZllsRWtma3BsdlhlRUZ2MGFrT19JNldDLVA3YjMxbU9Cc1IwMEFLLW9yWnNN?oc=5","date":"2025-10-06","type":"trial","source":"Nature","summary":"Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV - Nature","headline":"Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxOWmJTRTlNczExVGJWYTBib1hna2ZRY25NX3hsN29hQ1B4akVuRlVsVE0tSEk4YjdzU1hTN0xlZVBkUmhZdDJTal9lTjZUbzhaTTRZTV9ZSlZuUDd6T19tNnpXRXpndjJPamdSYWdyTmJhalluSGlnUURVZGdfcU42RG41SGVNVGJVVHc?oc=5","date":"2025-06-19","type":"pipeline","source":"The New York Times","summary":"South Africa Built a Medical Research Powerhouse. Trump Cuts Have Demolished It. - The New York Times","headline":"South Africa Built a Medical Research Powerhouse. Trump Cuts Have Demolished It.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPdjJEeEFYRFhDZExwQWdZQzFOajJEMUpRekJWbkVZOERKaWhkcXVDR1l2SHFPRll1MDVNN1lYYmJ5OTZra0h1d2VMQ3BGeUNXV3JRVVVFcHc3dWdRM1JpLVhhNXd1OHI0dTh6RDdDR2p1SXBKVnBsUVNIMDFaV19xNFg3N2dGaWFSV0VuSWNGdGh6ejhmYWJqaA?oc=5","date":"2025-05-20","type":"pipeline","source":"Global Health NOW","summary":"U.S. Funding Cuts Stop Crucial HIV Research Work in Its Tracks - Global Health NOW","headline":"U.S. Funding Cuts Stop Crucial HIV Research Work in Its Tracks","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxQdDB4YU1QQWhsR0pjVTFMQXg0eVFzUmRKV2pBRWJMUjB1cGpRUl9mQ1ZCd3k1NS1RRW1LYTh4VWZyOGRiYXZmNW9WNjFDckVoOGtnYTFIa0l2ZXJYWk9adDctSFlsOVlIVG5MQ05uTmVEVkI1ZzRfZkVXNngxSFNxZkZ2cHBTazdqczdEQWowaXBiVm9rY3NGQldWc1g3N0J0WjVEaWdLTUZSSThrUFkxTEhYWVFxU244QmRUb1QtbkZ2dDBEVzhYZWMxbG9zTUlOeWh2MFN3?oc=5","date":"2025-05-14","type":"trial","source":"Reuters","summary":"Exclusive: HIV patient testing falls in South Africa after US aid cuts, data shows - Reuters","headline":"Exclusive: HIV patient testing falls in South Africa after US aid cuts, data shows","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1HanBvS2JpRFYyOF9MSG5mNjdJVnloMVJCNWlxb3ZtczBrM1VrOENpRHdQZy1aWDJMeHM2X0tNWEpQbG9qZVlrYjkzaFRGYkdTa1lZbklabENnSVVaZ1NZ?oc=5","date":"2025-05-07","type":"trial","source":"Nature","summary":"Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019 - Nature","headline":"Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPR3VrRWprRk1MQXcyck1odmtCcDVVbnRZNFd2LXBFazh1aEdyUEE2Tlpqek1fUXNOZE5qMlNKNnlhU003clN0Y2Zmd1V5T1RhR292X0RDRUY0c0wxTnJHeEU2b3V2NFBieTZJLXZRSHZQcFB3YlpGXzd1THV5MTJyRkhhWHFjZ0xWLTZLS21jOXN1TzhkWG5zYVNabXo?oc=5","date":"2025-03-31","type":"pipeline","source":"UNAIDS","summary":"Impact of US funding cuts on HIV programmes in East and Southern Africa - UNAIDS","headline":"Impact of US funding cuts on HIV programmes in East and Southern Africa","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQWGNiOUJzU3dzRkJqdEdaRksxa0U0V1MtRkxpQU1TZ2NRZTVoS3kzb0FEY1hYRFpqVnhEYnZVVF9DdGI4NnBpbEdfUFlhRldpdTYybFZEVjhHOWlrX25DUV9Yc3FTMnFjRDJRYzkwQVA3cVE4V09Dc2wwZG1KSjVNNDJNcERhejJIcDJ0Z0FrVTdNbVBQclZZejhHYl9yOUU3TUU2bjNNeDdaaEQ1V1luNWhuLVI?oc=5","date":"2025-02-13","type":"trial","source":"Science | AAAS","summary":"Researchers face impossible decisions as U.S. aid freeze halts clinical trials - Science | AAAS","headline":"Researchers face impossible decisions as U.S. aid freeze halts clinical trials - Science | AAAS","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOSjVSRmY3a2RPREs1bFNhZzFWODlBMXBwZzVpdHdlRExrSF9IOG9aR1ZicmFjVi00TzZaMmZpSjZfSHd5VkMtdDlTVW1FTE5hN0tLVE1PU3RzVG51Qk9KR3VMVUI5WkJaenhLV3JfclRObFNzSk9EX0ZrSkw4S09Rbm1aSWkzUFpjZEZBQ3UwMUJPeHltQmVlak5ycmJyQQ?oc=5","date":"2025-01-29","type":"pipeline","source":"Context News","summary":"How the US came to fund global treatment for HIV/AIDS - Context News","headline":"How the US came to fund global treatment for HIV/AIDS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE54bGdKNXk0TGV3NGhwaFdCcHJSN2Y1eXhwOWtjYXVyeHptekhIVGo2OW8tOEdveUpiTXJfT21MVU5CNk1Qbmo4LWt0Q0tjQlR1bHNla1JoVi1xUUp4eVdfMGoyakFwWlBGYkZkS2syRjBFQjF3d0Jv?oc=5","date":"2023-12-27","type":"pipeline","source":"IAVI","summary":"An industry leader in HIV research - IAVI","headline":"An industry leader in HIV research","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE5nVzQyMUl5bHRZY3dHUGF1RFNzVnZHS05rR0RWYnZHR2d1cDI3RkJvcVV4eExIMnh1VmVsLWJQSTQ0VURzYW1HQW82a0g0MXJZREIwMmFPemt0SDRtelFqQ3NxR2oxcmFCcEpB?oc=5","date":"2022-10-26","type":"pipeline","source":"Wiley Online Library","summary":"Journal of the International AIDS Society | IAS HIV Research Journal - Wiley Online Library","headline":"Journal of the International AIDS Society | IAS HIV Research Journal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNa05ESDFZeHNoVEMwRnU5UGNoOGlqOU1xQmpKWHJ5cGZ1a0dPakZncVlrMTJxeUc3ajhKTU1LMURESDMwXzEtUW1PQzV0TzhwaWZWYUpJZXV2QUdSRVBRdjZoTk5kT2Z6N0ZfcVRqcE1iXzJXZjVTODdHZklXM3IwZ3hYSnAxUXlhQ0HSAY8BQVVfeXFMTUU2REItUk9BTGpFSG9BbGxUeWpmVWZPaHhMaS1zSXY2SWVtRFJDVFBkdjktXzk2TXFKMFI0TTJ6Qm94dGtyc3JuaWkwenlydmYxMzZQUXgzMU5BVVNDVzI1aFJIS0FJU21zSE5pbUtubFRkbFpKRGU2U2MxMlhRN25RR1l5VmlOZUFBczFELXM?oc=5","date":"2016-07-22","type":"pipeline","source":"PBS","summary":"Can South Africa meet its ambitious goal to end AIDS? - PBS","headline":"Can South Africa meet its ambitious goal to end AIDS?","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}